Skip to main content
. 2024 Dec 30;36(6):729–741. doi: 10.21147/j.issn.1000-9604.2024.06.10

Table 1. Point assignments for CPS+EG, Neo-Bioscore, and CPS+EGHlow staging systems.

Cancer stage CPS+EG CPS+EGHlow Neo-Bioscore
ER, estrogen receptor; HER2, human epidermal growth factor receptor 2.
Clinical stage
 I 0 0 0
 IIA 0 0 0
 IIB 1 1 1
 IIIA 1 1 1
 IIIB 2 2 2
 IIIC 2 2 2
Pathologic stage
 0 0 0 0
 I 0 0 0
 IIA 1 1 1
 IIB 1 1 1
 IIIA 1 1 1
 IIIB 1 1 1
 IIIC 2 2 2
Tumor marker
 ER-negative 1 1 1
 Grade 3 1 1 1
 HER2-zero 2 1
 HER2-low 1 1
 HER2-amplified 0 0